[go: up one dir, main page]

PE20070323A1 - Composicion que comprende 4-(2,4-dicloro-5-metoxi-fenilamino)-6-metoxi-7-[3-(4-metil-piperazin-1-il)-propoxi]-quinolin-3-carbonitrilo como inhibidor de tirosina quinasa - Google Patents

Composicion que comprende 4-(2,4-dicloro-5-metoxi-fenilamino)-6-metoxi-7-[3-(4-metil-piperazin-1-il)-propoxi]-quinolin-3-carbonitrilo como inhibidor de tirosina quinasa

Info

Publication number
PE20070323A1
PE20070323A1 PE2006000716A PE2006000716A PE20070323A1 PE 20070323 A1 PE20070323 A1 PE 20070323A1 PE 2006000716 A PE2006000716 A PE 2006000716A PE 2006000716 A PE2006000716 A PE 2006000716A PE 20070323 A1 PE20070323 A1 PE 20070323A1
Authority
PE
Peru
Prior art keywords
metoxy
propoxi
phenylamine
quinolin
carbonitrile
Prior art date
Application number
PE2006000716A
Other languages
English (en)
Inventor
Frank Charles Boschelli
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37575124&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20070323(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PE20070323A1 publication Critical patent/PE20070323A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE: A) 4-(2,4-DICLORO-5-METOXI-FENILAMINO)-6-METOXI-7-[3-(4-METIL-PIPERAZIN-1-IL)-PROPOXI]-QUINOLIN-3-CARBONITRILO (SKI-606) COMO PRINCIPIO ACTIVO; Y B) UN PORTADOR FARMACEUTICAMENTE ACEPTABLE TAL COMO UN DILUYENTE, AEROSOL, UNA SOLUCION ACUOSA, ENTRE OTROS. DICHA COMPOSICION INHIBE LA TIROSINA QUINASA Y PUEDE SER ADMINISTRADA CON OTRO COMPUESTO TAL COMO MESILATO DE IMATINIB, GEMCITABINA, AVASTINA, ENTRE OTROS, SIENDO UTIL PARA EL TRATAMIENTO DE CANCER PANCREATICO, CANCER DE PROSTATA, CANCER DE CABEZA Y CUELLO, MELANOMA
PE2006000716A 2005-06-24 2006-06-22 Composicion que comprende 4-(2,4-dicloro-5-metoxi-fenilamino)-6-metoxi-7-[3-(4-metil-piperazin-1-il)-propoxi]-quinolin-3-carbonitrilo como inhibidor de tirosina quinasa PE20070323A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69367105P 2005-06-24 2005-06-24

Publications (1)

Publication Number Publication Date
PE20070323A1 true PE20070323A1 (es) 2007-05-04

Family

ID=37575124

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2006000716A PE20070323A1 (es) 2005-06-24 2006-06-22 Composicion que comprende 4-(2,4-dicloro-5-metoxi-fenilamino)-6-metoxi-7-[3-(4-metil-piperazin-1-il)-propoxi]-quinolin-3-carbonitrilo como inhibidor de tirosina quinasa

Country Status (20)

Country Link
US (1) US20070010527A1 (es)
EP (1) EP1893209A2 (es)
JP (1) JP2008546777A (es)
KR (1) KR20080027275A (es)
CN (1) CN101252931A (es)
AR (1) AR057403A1 (es)
AU (1) AU2006262591A1 (es)
BR (1) BRPI0611977A2 (es)
CA (1) CA2610209A1 (es)
CR (1) CR9539A (es)
EC (1) ECSP078015A (es)
GT (1) GT200600268A (es)
IL (1) IL187792A0 (es)
MX (1) MX2007016542A (es)
NI (1) NI200700323A (es)
NO (1) NO20076075L (es)
PE (1) PE20070323A1 (es)
RU (1) RU2007143434A (es)
TW (1) TW200730177A (es)
WO (1) WO2007001839A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2007148072A (ru) * 2005-07-01 2009-08-10 Вайет (Us) Кристаллические формы 4-[(2,4-дихлор-5-метоксифинил)амино]-6- меокси-7-[3-(4-метил-1-пиперазинил)пропокси]-3-хиналинкарбонитрил и способы их получения
WO2013187967A1 (en) * 2012-06-15 2013-12-19 Institute For Cancer Research D/B/A The Research Institute Of Fox Case Cancer Center ("Fox Chase Cancer Center") Sensitization of cancer cells to dna damage by inhibiting kinases essential for dna damage checkpoint control
WO2017134679A1 (en) * 2016-02-03 2017-08-10 Msn Laboratories Private Limited Novel crystalline polymorphs of 4-[(2.4-dichioro-5-methoxvphenvl)aniinol- 6-methoxv-7-13-(4-methyl-l-piperazinvl)propoxvl-3-quinolinecarbonitrile and process for preparation thereof
CN107433391B (zh) * 2017-07-03 2020-01-17 武汉逸飞激光设备有限公司 一种基于图像识别的焊接校准方法及系统

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6002008A (en) * 1997-04-03 1999-12-14 American Cyanamid Company Substituted 3-cyano quinolines
US6432979B1 (en) * 1999-08-12 2002-08-13 American Cyanamid Company Method of treating or inhibiting colonic polyps and colorectal cancer
US6384051B1 (en) * 2000-03-13 2002-05-07 American Cyanamid Company Method of treating or inhibiting colonic polyps
UA77200C2 (en) * 2001-08-07 2006-11-15 Wyeth Corp Antineoplastic combination of cci-779 and bkb-569
CA2543163A1 (en) * 2003-11-06 2005-05-26 Wyeth 4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (cml)

Also Published As

Publication number Publication date
RU2007143434A (ru) 2009-07-27
JP2008546777A (ja) 2008-12-25
EP1893209A2 (en) 2008-03-05
NO20076075L (no) 2008-03-18
CN101252931A (zh) 2008-08-27
NI200700323A (es) 2008-06-25
GT200600268A (es) 2007-06-18
US20070010527A1 (en) 2007-01-11
TW200730177A (en) 2007-08-16
ECSP078015A (es) 2008-01-23
KR20080027275A (ko) 2008-03-26
CA2610209A1 (en) 2007-01-04
MX2007016542A (es) 2008-03-04
AU2006262591A1 (en) 2007-01-04
CR9539A (es) 2008-02-20
IL187792A0 (en) 2008-11-03
WO2007001839A2 (en) 2007-01-04
WO2007001839A3 (en) 2007-04-26
AR057403A1 (es) 2007-12-05
BRPI0611977A2 (pt) 2010-10-13

Similar Documents

Publication Publication Date Title
CR9875A (es) Inhibidores de dipeptidilo peptidasa para tratar diabetes
PE20090895A1 (es) Derivados de triazol como inhibidores de la jak quinasa
NO20076648L (no) Novel thiophene derivatives
EP2178870A4 (en) INDOL AND INDAZONE COMPOUNDS AS AN INHIBITORS OF CELL NECROSIS
NO20083630L (no) Nye pyridinderivater
PE20141585A1 (es) Composicion farmaceutica estabilizada a base de un compuesto no petidico
CU23784B7 (es) Bencimidazoles sustituidos como inhibidores de cinasa
MA30725B1 (fr) Administration d'inhibiteurs de la dipeptidyl peptidase
AR041089A1 (es) Procedimiento y composiciones farmaceutiicas para tratar aterosclerosis, dislipidemias y afecciones relacionadas
NO20082793L (no) Nye tiofenderivater
CL2009000394A1 (es) Compuestos derivados de n-(1h-indazol-5-il)pirrolidin-3-carboxamida sustituida, inhibidores de erk; composicion farmaceutica; y su uso en el tratamiento del cancer.
PE20060464A1 (es) Composicion farmaceutica que comprende flibanserina para el tratamiento de trastornos sexuales
PE20121050A1 (es) Compuestos de n-(1-(4-(1h-pirazol-5-il)ftalazin-1-il)piperidin-4-il)-benzamida sustituidos como antagonistas de la trayectoria hedgehog
NO20075298L (no) Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
AR074471A1 (es) Compuesto 5(5-(2-(3-aminopropoxi) - 6 - metoxifenil) -1h- pirazol-3- ilamino ) pirazin -2-carbonitrilo , composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para inhibir chk1 y para tratar cancer
CU23550B7 (es) Derivados de pirrolo-pirazol sustituidos como inhibidores de quinasa
ECSP088974A (es) Derivados de imidazol pirimidina para el tratamiento de enfermedades relacionadas con la glicógeno sintasa quinasa (gsk3)
MX2007003546A (es) Derivados de indozolona como inhibidores de 11-beta- hidroxiesteroide-deshidrogenasa.
EA201170703A1 (ru) Производные адамантилбензамида
PE20140934A1 (es) Derivados de pirazol
MA32563B1 (fr) Dabigatran pour cathétérisme cardiaque de chirurgie percutanée
CR10495A (es) Composicion que comprende por lo menos un alcohol alifatico superior y un extracto de griffonia simplicifolia
PL1703905T3 (pl) Pochodne indolu i ich zastosowanie jako inhibitorów kinazy, zwłaszcza inhibitorów IKK2
CO6612226A2 (es) Tableta
PE20091032A1 (es) Composicion que contiene n-(3-metoxi-5-metilpirazin-2-il)-2-(4-[1,3,4-oxadiazol-2-il]fenil)piridin-3-sulfonamida (zibotentan)

Legal Events

Date Code Title Description
FC Refusal